Pfizer announced this week that they were asking the FDA to issue an emergency use authorization (EUA) for a “booster” COVID-19 vaccine for children between the ages of 5 and 11.

The FDA issued an EUA for the first Pfizer COVID-19 shots for this age group of children in October of 2021.

At the time, a doctor on the FDA Advisory Committee deliberating on whether or not an EUA should be given for this age group, stated that the only way to find out if the Pfizer COVID-19 vaccines were safe for this age group was to start injecting them with it.

“We’re never gonna learn about how safe the vaccine is until we start giving it, and that’s just the way it goes.”

So far over 10,000 cases have been filed to VAERS (Vaccine Adverse Event Reporting System) of deaths and injuries among children in this age group following the experimental COVID-19 vaccines.

By way of contrast, there have been 939 cases of vaccine adverse events during this same time period for all of the FDA approved vaccines for children in this age group.

That means there has been an increase of over 1000% of vaccine injuries and deaths for this age group following the COVID-19 vaccines.